India to South Africa: Efavirenz Export Trade Route

The India to South Africa Efavirenz corridor is one of India's established pharmaceutical export routes, with 53 shipments documented worth a combined $29.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's efavirenz manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $558.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with efavirenz's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 15.0%, placing it at rank #12 among India's top efavirenz export destinations globally.

On the import side, key buyers of Indian efavirenz in South Africa include VIATRIS HEALTHCARE (PTY) LTD,, MACLEODS PHARMACEUTICALS SA, NATIONAL EMERGENCY RESPONSE COUNCIL HIV and 11 others. VIATRIS HEALTHCARE (PTY) LTD, is the single largest importer with 4 shipments valued at $13.6M USD.

India's efavirenz exports to South Africa are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LIMITED — together account for 93% of total trade value on this route. The average shipment value of $558.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as triolar tablets (efavirenz 600mg emtricitabine 200mg tenofovir 300mg tablets) bno:beb92310a md.10/23 ed.09/25 ps: 1x30s and triolar tablets (efavirenz 600mg emtricitabine 200mg tenofovir 300mg tablets) bno:beb92309a md.09/23 ed.08/25 ps: 1x30s, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, VIATRIS HEALTHCARE (PTY) LTD, is the largest importer with 4 shipments worth $13.6M USD — representing 46% of all efavirenz imports from India on this route. A total of 14 buyers are active on this corridor.